相关实验视频
Updated: Jul 14, 2026

05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
制药行业作为药品提供商的制药行业
1School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales, Australia. mddah@mail.newcastle.edu.au
Lancet (London, England)
|November 22, 2002
概括
高昂的药品价格限制了全球的药品获取. 虽然知识产权受到争议,但自愿许可可能会改善发展中国家的基本药物供应.
科学领域:
- 制药政策 制药政策
- 全球卫生公平性全球卫生公平性
- 知识产权知识产权知识产权的权利.
背景情况:
- 药品价格的上造成了获取障碍,特别是在低收入国家.
- 目前的药物开发模式不足以满足欠发达国家的基本卫生需求.
- 制药行业援引高开发成本来证明专利保护和高价格的合理性.
研究的目的:
- 检查知识产权对医药可访问性的影响.
- 探索改善发展中国家获得基本药物的潜在解决方案.
主要方法:
- 对国际知识产权制度的分析.
- 世界贸易组织政策调整的审查.
- 对价格差异和自愿许可模式的评估.
主要成果:
- 关于药物创新的高价和专利保护是否必要存在争议.
- 世界贸易组织减轻了对最不发达国家的要求,并促进了价格差异.
- 这些措施对没有国内生产能力的国家的有效性仍然不确定.
结论:
- 自愿许可协议为改善获得基本药物的途径提供了潜在的途径.
- 解决药物的负担能力和可访问性需要创新的政策解决方案.
- 全球卫生战略必须考虑发展中国家在获得药品方面所面临的独特挑战.
关键词:
医疗保健和公共卫生相关概念视频
Drug Nomenclature
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

